Patient Care

Find specialists supported by world-renowned researchers & educators.

You can learn more about conditions, treatments, or procedures, or use the keyword library as a starting point to find related specialists, departments, and informational fact sheets on Yale Medicine.

Go to the keyword library

Information for referring doctors

Refer a patient

Yale Medicine patients receive care from some of the world’s most renowned doctors.

As the clinical practice for the Yale School of Medicine, Yale Medicine’s more than 1,500 doctors play multiple roles in advancing the practice of medicine – from treating and caring for patients, to developing new cures through innovative research, to educating future doctors.

We are the largest academic multispecialty practice in New England. Our doctors and researchers work together to achieve the best care possible.

Yale Medicine offers specialist expertise, advanced and innovative technology and a multidisciplinary approach. We deliver exceptional medical care in a nurturing environment to each of our patients, every day.

Departments & Collaborative Centers

News from Yale Medicine

Family Health

Clinical Trials

Phase 1 Cancers

A Dose-escalation, Dose-finding, and Expansion Study of XL495 as a Single Agent and in Combination Therapy in Participants With Locally Advanced or Metastatic Solid Tumors

AgeANY

GenderANY

Date14 February

See details

Phase 1 Cancers

A First-in-human Open Label Phase Ia/Ib, Multicenter/Multiregional, Dose Escalation Study of BI 765883 Administered Intravenously as Monotherapy and in Combination With Gemcitabine and Nab-paclitaxel in Unselected Patients With Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) or Patients With PDAC Who Have Relapsed Within 6 Months After Post-surgery Adjuvant Therapy

AgeANY

GenderANY

Date7 October

See details

Leukemia

A Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combination) Versus Subcutaneous Azacitidine in Subjects With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)

AgeANY

GenderANY

Date31 July

See details

Head and Neck Cancers

A Multicenter, Randomized, Double Blind, Placebo - Controlled, Phase 3 Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV -Negative Head and Neck Squamous Cell Carcinoma. (FIERCE-HN)

Age>=18 years

GenderNon Binary

Date20 June

See details

Show more trials from Yale Medicine

Patient Care from Yale Medicine

Yale Medicine patients receive care from some of the world’s most renowned doctors.

Departments & Collaborative Centers

Fact Sheets

2025/03/12 Fact Sheet Automation

Wide-Awake Needle Arthroscopy

Endobronchial Valve Placement

Atrial Fibrillation

News from Yale Medicine

HMPV (Human Metapneumovirus): Your Questions Answered

‘Heart in a Box:’ Technology Expands Access to Organ Transplant

Yale Medicine Takes Top Spots in National, State Rankings

Clinical Trials

A Dose-escalation, Dose-finding, and Expansion Study of XL495 as a Single Agent and in Combination Therapy in Participants With Locally Advanced or Metastatic Solid Tumors

A Multicenter, Randomized, Double Blind, Placebo - Controlled, Phase 3 Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV -Negative Head and Neck Squamous Cell Carcinoma. (FIERCE-HN)